Whole-Body Hyperthermia with IRATHERM1000M
Medically supervised whole-body hyperthermia in Atlanta with the IRATHERM1000M by VON ARDENNE, exploring the effects of controlled heat on circulation, immune activity, and cellular responses.
What Is Whole-Body Hyperthermia with IRATHERM1000M?
When you are fighting cancer or a complex immune condition, every tool matters. You want care that supports your body's natural defenses, not just treats symptoms. Whole-body hyperthermia with the IRATHERM1000M is one of the newest additions to our integrative toolkit, available to eligible participants through our IRB-overseen clinical study, coordinated with your existing care.
Hyperthermia therapy is a controlled medical treatment that raises the body's temperature and can influence immune activity, circulation, and cellular stress responses. The name refers to a therapeutic elevation of body temperature, not hypothermia, which describes a dangerous drop. At PMC, whole-body hyperthermia with the IRATHERM1000M is administered under the direct supervision of a medical provider who monitors your core temperature throughout the session.
The concept is rooted in a simple biological principle: when the body's temperature rises, heat can influence immune activity. Researchers study changes in white blood cell function, and blood flow can increase. Some hyperthermia techniques also make tumor tissue more susceptible to certain conventional treatments. These effects depend on the heating method, temperature, and treatment setting. This research helps explain interest in hyperthermia within integrative medicine and oncology.
Meet the IRATHERM1000M
German Technology with a Personalized Approach
At Progressive Medical Center, we use the IRATHERM1000M by VON ARDENNE, a medical technology company based in Dresden, Germany. Designed for medically supervised whole-body hyperthermia, this system uses specially filtered infrared heat to gradually raise your body temperature. You rest on an open treatment bed while your care team monitors your temperature, heart rate, and oxygen levels throughout the session.
The IRATHERM1000M is used in German clinical settings, and VON ARDENNE describes its oncology applications as a complement to standard cancer treatment. The manufacturer lists colorectal cancer, cancers involving the lining of the abdominal cavity, and cancers of the head, face, and neck among its applications. The device also carries European medical device conformity documentation. This background provides context for the technology and its use overseas; it does not establish the same treatment benefits or authorization in the United States.
At Progressive, we bring this technology into a medically supervised research setting. Eligible participants receive IRATHERM1000M sessions through our IRB-overseen clinical study examining microplastics and oxidative stress biomarkers. Your team explains the study, reviews your health history, and answers your questions before you decide whether to participate. Participation is voluntary, benefits are uncertain, and sessions follow the study protocol alongside your ongoing medical care.
Controlled Heat, Carefully Monitored
During an IRATHERM1000M session, your body temperature is gradually raised using water-filtered infrared-A radiation (wIRA). The system uses six radiators and an open treatment couch, allowing the care team access throughout the session. Unlike localized hyperthermia, PMC's IRATHERM1000M study uses whole-body heating. Four areas help explain the scientific interest in hyperthermia.
Immune Activation
Heat can trigger heat shock responses and influence immune cell activity, including natural killer cells, in experimental research.
Improved Circulation
Blood vessels dilate, increasing blood flow. The effect on oxygen and therapeutic agent delivery depends on the treatment setting.
Cancer Cell Vulnerability
In some oncology settings, heating tumor tissue can increase its susceptibility to chemotherapy or radiation. This depends on the hyperthermia technique and temperature.
Deeper Detoxification
Metabolic activity and deep sweating rise, supporting the body's natural detoxification pathways.
During your IRATHERM1000M session, your provider monitors your core temperature, heart rate, and comfort level throughout the entire session. The temperature is increased gradually, held within protocol-specified temperature limits, then brought back down in a controlled cooldown. The experience may feel like sustained warmth. Heat discomfort and temporary fatigue may occur, and individual responses vary.
What Hyperthermia Therapy Can Do
Hyperthermia activates multiple healing pathways simultaneously. Here are the primary benefits patients and researchers have observed.
The following describes broader hyperthermia research and proposed biological effects. Results depend on device, temperature, condition, and treatment setting and should not be assumed to apply to PMC's IRATHERM1000M study.
Immune System Activation
Elevated body temperature stimulates the production and activity of white blood cells, natural killer cells, and other immune components. This heightened immune response helps the body identify and respond to abnormal cells more effectively, which is particularly relevant for cancer patients.
Enhanced Treatment Effectiveness
Research has shown that hyperthermia can enhance the effectiveness of certain other therapies when used in combination. Heat increases blood flow to tumors and affected areas, improving the delivery of therapeutic agents and oxygen to tissues that need them most.
Improved Circulation and Oxygenation
Heat causes blood vessels to dilate, increasing blood flow throughout the body. This improved circulation delivers more oxygen and nutrients to tissues while helping remove metabolic waste. For patients with compromised circulation or chronic inflammation, this systemic effect supports healing at a foundational level.
Detoxification Support
Whole-body hyperthermia promotes deep sweating and increased metabolic activity, supporting the body's natural detoxification pathways. For patients dealing with toxic burden, environmental exposures, or chronic infection, hyperthermia can help the body clear what it has been struggling to eliminate on its own.
Pain and Inflammation Reduction
Heat therapy has a long history of reducing pain and calming inflammation. Clinical hyperthermia takes this further by raising core temperature to levels that trigger systemic anti-inflammatory responses. Patients with chronic pain conditions, autoimmune disorders, and fibromyalgia often experience relief as inflammatory markers decrease.
Cancer Cell Vulnerability
Cancer cells are less able to regulate heat than healthy cells. When body temperature rises, healthy cells adapt and continue functioning normally, but cancer cells become stressed and more susceptible to damage. This is why hyperthermia has become an area of growing interest in integrative oncology programs worldwide.
Conditions That Respond to Hyperthermia
Hyperthermia has been studied in oncology and is also discussed by people seeking options for chronic and complex conditions. The conditions below are topics for consultation, not established treatment indications for PMC's IRATHERM1000M study. Study eligibility is determined separately through protocol-based screening.
What to Expect
From your initial consultation through post-treatment recovery, here is what the IRATHERM1000M process looks like.
Consultation and Evaluation
Your provider reviews your health history, current diagnoses, treatment goals, and any ongoing therapies. Hyperthermia does not replace established treatment. Your doctor and study team determine whether you meet the IRATHERM1000M study criteria and how participation fits alongside your ongoing care. Before enrollment, you review the study procedures, risks, uncertain benefits, and participant costs and provide informed consent. If you are a cancer patient, your oncology history and current treatment status are factored into the decision.
Preparation
Before your IRATHERM1000M session, you will be asked to hydrate well and may receive specific preparation instructions from your care team. When you arrive, your provider takes baseline vitals and explains exactly what will happen during the session. Monitoring equipment is placed to track your core temperature and heart rate throughout.
The IRATHERM1000M Session
Your body temperature is gradually raised using the IRATHERM1000M's water-filtered infrared-A radiation and held within the study protocol's target range for a defined period determined by your protocol. Your provider is present throughout, monitoring your temperature, vitals, and comfort. The heat is increased slowly and adjusted according to protocol limits, your tolerance, and stopping criteria. The sensation may be described as a deep, sustained warmth.
Cooldown and Recovery
After the IRATHERM1000M heating period, your body temperature is brought back down in a controlled cooldown. You are monitored until your vitals return to baseline. Temporary fatigue may occur, and recovery varies. Your care team may recommend hydration, targeted supplements, or rest to support recovery. Follow-up sessions and lab testing help track how your body responds over time.
IRATHERM1000M as Part of a Comprehensive Plan
Many patients first hear about hyperthermia through cancer research or integrative oncology programs. At Progressive Medical Center, whole-body hyperthermia with the IRATHERM1000M is offered through our IRB-overseen study, with advanced diagnostics, coordinated care, and a team that works together. Participation is considered alongside your personalized clinical care.
Your IRATHERM1000M sessions are coordinated with your other treatments when appropriate and permitted by the study protocol. For cancer patients, the care team may also discuss separate services such as high-dose vitamin C IV therapy, EBOO, or hyperbaric oxygen, based on individual clinical assessment. For patients dealing with chronic infection or autoimmune conditions, separate care may include targeted IV protocols and naturopathic support. These services are evaluated individually; combining them with IRATHERM1000M is not required.
With decades of experience treating complex, chronic cases and a multidisciplinary team, PMC has the infrastructure to evaluate whether IRATHERM1000M study participation is appropriate for your specific situation and support you throughout the process.
IRATHERM1000M Whole-Body Hyperthermia vs. Sauna Therapy
IRATHERM1000M whole-body hyperthermia is sometimes confused with sauna use. PMC offers both, and they serve fundamentally different purposes.
Sauna / Infrared Sauna
- Heats the air or surface around the body
- Core temperature can rise, depending on heat exposure and duration
- Typically no continuous medical monitoring
- General wellness, relaxation
- Self-directed duration and intensity
- Typically used for general wellness
IRATHERM1000M at PMC
- Raises core body temperature to a protocol-specified target range
- Controlled heating with water-filtered infrared-A radiation and real-time monitoring
- Administered and supervised by a medical provider
- Medically monitored whole-body heating with IRATHERM1000M within a clinical study
- Duration and intensity guided by the study protocol and medical screening
- Coordinated with diagnostics and your care team under the IRATHERM1000M study protocol
Therapies That May Be Coordinated with IRATHERM1000M Study Participation
Hyperthermia research often explores its use alongside other treatments. At PMC, your team reviews any additional services for clinical appropriateness and compatibility with the IRATHERM1000M study protocol. The services below may be discussed separately; they are not established to enhance the study intervention.
IV Therapy
High-dose vitamin C, curcumin, and other IV protocols are available within PMC's broader integrative care offerings. Your provider reviews whether an IV service is appropriate for you and compatible with study participation. Any proposed combination must be consistent with the protocol; improved outcomes from combining IV therapy with IRATHERM1000M have not been established.
Learn moreEBOO Therapy
EBOO is another service available through PMC. Your provider can explain its proposed role, risks, and whether it is appropriate within your individual care plan. Any use alongside hyperthermia requires review for compatibility with the study protocol; a detoxification or recovery benefit from this combination has not been established.
Learn moreDiagnostic Testing
Advanced functional diagnostics reveal the specific markers, imbalances, and immune challenges that inform your broader care plan. Protocol-specified lab testing tracks the IRATHERM1000M study's microplastics and oxidative stress biomarkers. Any additional clinical testing is discussed separately.
Learn moreIRATHERM1000M Whole-Body Hyperthermia FAQ
What are the risks of IRATHERM1000M whole-body hyperthermia?
At PMC, IRATHERM1000M sessions are medically supervised, with monitoring of your core temperature, heart rate, and comfort throughout. Heat is increased gradually within the study protocol's limits and adjusted or stopped when needed. Medical screening and monitoring help manage risks, but do not eliminate them. Possible side effects include heat discomfort, fatigue, dehydration, and nausea; more serious complications can include heart and blood vessel problems. Your team explains the study-specific risks before you decide whether to participate.
How is this different from an infrared sauna?
Both use heat, but the equipment, monitoring, and purpose differ. Infrared saunas are generally used for wellness and relaxation, and their effect on core temperature varies. IRATHERM1000M uses water-filtered infrared-A radiation to gradually raise core temperature on an open treatment bed, with medical monitoring throughout the session. At PMC, these sessions follow our clinical study protocol. We offer both infrared sauna therapy and whole-body hyperthermia study sessions, and your provider can explain the options.
Who is a candidate for the IRATHERM1000M study?
People exploring hyperthermia may have questions about cancer support, immune health, or chronic conditions. At PMC, participation in the IRATHERM1000M study depends on medical screening and the study's eligibility criteria. Your team reviews your health history, medications, and current treatments to determine whether you qualify and whether participation is appropriate for you. A diagnosis alone does not determine eligibility.
What does an IRATHERM1000M session feel like?
You will feel a gradual warming sensation as the IRATHERM1000M raises your body temperature. You rest on an open treatment bed while your care team monitors your vital signs and comfort. The warmth can become intense, and you should tell your team about any discomfort. After the heating phase, you undergo a monitored cooldown. Temporary fatigue may occur, and recovery varies from person to person.
How many sessions will I need?
The number of sessions, their timing, and follow-up testing are outlined in the study protocol. Your team explains the schedule and time commitment before you enroll. Your response and medical assessment may lead the team to adjust or stop participation according to the protocol.
Can IRATHERM1000M study participation be coordinated with conventional cancer treatment?
Certain forms of hyperthermia are used alongside chemotherapy or radiation in oncology settings. At PMC, IRATHERM1000M is offered through our clinical study, rather than as an established cancer treatment. If you are receiving cancer care, your study team reviews your current treatment and coordinates with your oncologist to assess whether participation is appropriate and permitted by the protocol. Participation does not replace or require stopping conventional cancer care.
Can IRATHERM1000M study participation be coordinated with other PMC therapies?
Your provider may discuss separate PMC services, such as IV therapy, EBOO, hyperbaric oxygen, or additional diagnostic testing, as part of your broader care. Any use alongside IRATHERM1000M sessions must be reviewed for medical appropriateness and compatibility with the study protocol. These services are not automatically required for participation, and combining them with IRATHERM1000M has not been established to improve study outcomes.
Do I need a referral?
No referral is needed to schedule an initial consultation. Call (770) 676-6000 or book a consultation online. Your team will discuss your questions, review your health history, and explain whether you may qualify for the IRATHERM1000M study. Enrollment requires screening and informed consent.
Why is IRATHERM1000M offered through a clinical study at PMC?
Our study examines microplastics and oxidative stress biomarkers before and after whole-body hyperthermia sessions. It is overseen by an Institutional Review Board, or IRB, which reviews research protections for participants. This use of IRATHERM1000M is investigational, and individual health benefits are uncertain. Before enrolling, you receive information about the procedures, risks, schedule, and participant costs so you can make an informed decision.
Does its European status mean it is approved to treat cancer at PMC?
No. VON ARDENNE's European conformity documentation and listed oncology applications describe a separate regulatory and clinical context. PMC's use is investigational within its IRB-overseen study, and research participation does not replace established cancer treatment.
Ready to Explore Whole-Body Hyperthermia with IRATHERM1000M?
No referral is needed to schedule an initial consultation. Your team will discuss your questions, review your health history, and explain whether you may qualify for the IRATHERM1000M study. Enrollment requires screening and informed consent.